[HTML][HTML] Molecular and functional identification of sodium ion-dependent, high affinity human carnitine transporter OCTN2

I Tamai, R Ohashi, J Nezu, H Yabuuchi, A Oku… - Journal of Biological …, 1998 - ASBMB
Primary carnitine deficiency, because of a defect of the tissue plasma membrane carnitine
transporters, causes critical symptoms. However, the transporter has not been molecularly …

Primary systemic carnitine deficiency is caused by mutations in a gene encoding sodium ion-dependent carnitine transporter

J Nezu, I Tamai, A Oku, R Ohashi, H Yabuuchi… - Nature …, 1999 - nature.com
Primary systemic carnitine deficiency (SCD; OMIM 212140) is an autosomal recessive disorder
characterized by progressive cardiomyopathy, skeletal myopathy, hypoglycaemia and …

ABC transporter AtABCG25 is involved in abscisic acid transport and responses

T Kuromori, T Miyaji, H Yabuuchi… - Proceedings of the …, 2010 - National Acad Sciences
Abscisic acid (ABA) is one of the most important phytohormones involved in abiotic stress
responses, seed maturation, germination, and senescence. ABA is predominantly produced in …

Cloning and characterization of a novel human pH‐dependent organic cation transporter, OCTN1

I Tamai, H Yabuuchi, J Nezu, Y Sai, A Oku… - FEBS …, 1997 - Wiley Online Library
cDNA for a novel proton/organic cation transporter, OCTN1, was cloned from human fetal liver
and its transport activity was investigated. OCTN1 encodes a 551‐amino acid protein with …

Novel membrane transporter OCTN1 mediates multispecific, bidirectional, and pH-dependent transport of organic cations

H Yabuuchi, I Tamai, JI Nezu, K Sakamoto, A Oku… - … of Pharmacology and …, 1999 - ASPET
In the present study, functional characteristics of organic cation transporter (OCTN)1, which
was cloned as the pH-dependent tetraethylammonium (TEA) transporter when expressed in …

Na+-dependent carnitine transport by organic cation transporter (OCTN2): its pharmacological and toxicological relevance

R Ohashi, I Tamai, H Yabuuchi, JI Nezu, A Oku… - … of Pharmacology and …, 1999 - ASPET
Carnitine deficiency, either primary or drug-induced, causes critical symptoms and is thought
to involve alteration of active transport of carnitine across the plasma membrane of tissues …

Gefitinib, an EGFR tyrosine kinase inhibitor, directly inhibits the function of P-glycoprotein in multidrug resistant cancer cells

…, S Doi, M Yasunaga, M Takemura, H Yabuuchi… - Lung cancer, 2005 - Elsevier
Gefitinib (Iressa™) is a selective epidermal growth factor receptor tyrosine kinase inhibitor
and is used for the treatment of lung cancer. Recently, we discovered that it inhibits the breast …

SLCO4C1 transporter eliminates uremic toxins and attenuates hypertension and renal inflammation

…, M Tauc, Y Fujii-Kuriyama, H Yabuuchi… - Journal of the …, 2009 - journals.lww.com
Hypertension in patients with chronic kidney disease (CKD) strongly associates with
cardiovascular events. Among patients with CKD, reducing the accumulation of uremic toxins may …

p-Aminohippuric acid transport at renal apical membrane mediated by human inorganic phosphate transporter NPT1

…, K Yamashita, Y Minemoto, Y Sai, H Yabuuchi… - Biochemical and …, 2000 - Elsevier
Organic anions are secreted into urine via organic anion transporters across the renal
basolateral and apical membranes. However, no apical membrane transporter for organic anions …

Involvement of uric acid transporters in alteration of serum uric acid level by angiotensin II receptor blockers

…, T Iwanaga, H Mamada, T Ogihara, H Yabuuchi… - Pharmaceutical …, 2008 - Springer
Purpose To examine the mechanisms of the alteration of serum uric acid level by angiotensin
II receptor blockers (ARBs), the effects of ARBs on renal uric acid transporters, including …